Identification
Instrument name
VALBIOTIS
Symbol
ALVAL
ISIN code
FR0013254851
Exchange / Market
Euronext Growth
Trading location
Paris
Products family
Stocks
ICB
Biotechnology
Website address
Operation
IPO date
IPO price
EUR 10.50
Issue type
Initial Public offering
Catégorie
IPO
Price range
EUR 8.93 - EUR 12.07

Company profile

VALBIOTIS is a French Research & Development company committed to scientific innovation for the prevention and control of metabolic diseases.VALBIOTIS specializes in the development of innovative nutritional solutions for cardio-metabolic disease prevention and nutritional support for patients. The products are intended for food and pharmaceutical industries. Valbiotis is essentially intervening in the prevention of type 2 diabetes, NASH (non-alcoholic steatohepatitis), obesity and cardiovascular diseases. VALBIOTIS has established numerous partnerships with academic centers of excellence in France and overseas, including the University of La Rochelle, the CNRS, and the Clermont Auvergne University in Clermont-Ferrand where the company has opened a secondary school. With these agreements, since its inception Valbiotis has benefited from a strong leverage thanks notably to experts and technical partners involved in its projects.

Source: Cofisem - Last Update: 11 Aug 2020
Key Executives
Chairman of the Management Board Sébastien Peltier
Member of the Management Board Murielle Cazaubiel
Member of the Management Board Jocelyn Pineau
Member of the Management Board Pascal Sirvent
Administrative & Finance Director Jocelyn Pineau
Source: Cofisem - Last Update: 29 May 2020
Key figures
Millenium 2019 2018 2017 2016 2015
Net sales 91 79 3 10
Income from ordinary activities 1,310 1,509 782 646 381
Operating income -5,157 -4,876 -2,379 -572 -724
Cost of financial indebtedness net -358 -83 -76 -23 -20
Equity-accounted companies contribution to income
Net profit from discontinued activities
Net income -5,504 -4,967 -2,443 -593 -739
Net income (Group share) -5,504 -4,967 -2,443 -593 -739
Fiscal year end 12.19 12.18 12.17 12.16 12.15
Length of fiscal year (month) 12 12 12 12 23
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 11 Aug 2020
Shareholder information
Free float 79.13 %
Djanka Invesstissement 8.34 %
Amiral Gestion 5.78 %
Financière Eloujon 4.27 %
Nestadio 2.13 %
Pascal Sirvent 0.09 %
Member of the Supervisory Board 0.04 %
Source: Cofisem - Last Update: 17 Jul 2020